Literature DB >> 21473007

Two cases of benign neuromyelitis optica in patients with celiac disease.

R Bergamaschi, S Jarius, M Robotti, A Pichiecchio, B Wildemann, G Meola.   

Abstract

Neuromyelitis optica (NMO) is an autoimmune inflammatory disorder of the central nervous system, which predominately affects optic nerves and spinal cord. Celiac disease (CD) or gluten sensitivity is an autoimmune enteropathy triggered by ingestion of wheat gliadin and related proteins in genetically susceptible individuals. Although NMO is associated with other autoimmune disorders in around 30% of cases, an association of NMO with CD has rarely been reported. We describe two Caucasian women who, nineteen and two years after diagnosis of CD, respectively, had recurrent episodes of myelitis and optic neuritis consistent with the diagnosis of NMO. Despite numerous relapses, NMO followed an unusually mild course with no persistent neurological deficit, indicating that recurrent NMO can follow a benign course with complete remission. We discuss in detail a possible link between NMO and pre-existing CD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21473007     DOI: 10.1007/s00415-009-5288-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  The clinical course of neuromyelitis optica (Devic's syndrome).

Authors:  D M Wingerchuk; W F Hogancamp; P C O'Brien; B G Weinshenker
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

Review 2.  Celiac disease.

Authors:  Peter H R Green; Christophe Cellier
Journal:  N Engl J Med       Date:  2007-10-25       Impact factor: 91.245

3.  Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I.

Authors:  Armin Alaedini; Haruka Okamoto; Chiara Briani; Kurt Wollenberg; Holly A Shill; Khalafalla O Bushara; Howard W Sander; Peter H R Green; Mark Hallett; Norman Latov
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

4.  NMO-IgG in the diagnosis of neuromyelitis optica.

Authors:  S Jarius; D Franciotta; R Bergamaschi; H Wright; E Littleton; J Palace; R Hohlfeld; A Vincent
Journal:  Neurology       Date:  2007-02-07       Impact factor: 9.910

5.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

Review 6.  Neurological complications of coeliac disease: what is the evidence?

Authors:  G Grossman
Journal:  Pract Neurol       Date:  2008-04

Review 7.  Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.

Authors:  Sven Jarius; Friedemann Paul; Diego Franciotta; Patrick Waters; Frauke Zipp; Reinhard Hohlfeld; Angela Vincent; Brigitte Wildemann
Journal:  Nat Clin Pract Neurol       Date:  2008-03-11

8.  A patient with a benign course of neuromyelitis optica (Devic's syndrome) over 12 years: MRI follow up and histological findings.

Authors:  H Köller; E Neuen-Jacob; A Saleh; B C Kieseier; S Jander; H-P Hartung
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

9.  Does cryptic gluten sensitivity play a part in neurological illness?

Authors:  M Hadjivassiliou; A Gibson; G A Davies-Jones; A J Lobo; T J Stephenson; A Milford-Ward
Journal:  Lancet       Date:  1996-02-10       Impact factor: 79.321

10.  Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia.

Authors:  M Hadjivassiliou; M Mäki; D S Sanders; C A Williamson; R A Grünewald; N M Woodroofe; I R Korponay-Szabó
Journal:  Neurology       Date:  2006-02-14       Impact factor: 9.910

View more
  15 in total

1.  Aquaporin-4 seropositivity in a patient with coeliac disease but normal neurological examination and imaging.

Authors:  Patricia H McNamara; Lisa Costelloe; Yvonne Langan; Janice Redmond
Journal:  J Neurol       Date:  2010-11-05       Impact factor: 4.849

2.  Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.

Authors:  S Jarius; F Paul; K Ruprecht; B Wildemann
Journal:  J Neurol       Date:  2012-09-28       Impact factor: 4.849

3.  Optic neuritis in neuromyelitis optica.

Authors:  Marc H Levin; Jeffrey L Bennett; A S Verkman
Journal:  Prog Retin Eye Res       Date:  2013-03-30       Impact factor: 21.198

Review 4.  Ocular manifestations in celiac disease: an overview.

Authors:  Fotios S Fousekis; Andreas Katsanos; Konstantinos H Katsanos; Dimitrios K Christodoulou
Journal:  Int Ophthalmol       Date:  2020-01-08       Impact factor: 2.031

5.  [Diagnosis and treatment of neuromyelitis optica. Consensus recommendations of the Neuromyelitis Optica Study Group].

Authors:  C Trebst; A Berthele; S Jarius; T Kümpfel; S Schippling; B Wildemann; C Wilke
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

6.  Clinical relevance of serum aquaporin-4 antibody levels in neuromyelitis optica.

Authors:  Noriko Isobe; Tomomi Yonekawa; Takuya Matsushita; Katsuhisa Masaki; Satoshi Yoshimura; Jakub Fichna; Shu Chen; Jadwiga Furmaniak; Bernard Rees Smith; Jun-Ichi Kira
Journal:  Neurochem Res       Date:  2013-03-02       Impact factor: 3.996

7.  Neuromyelitis optica and myasthenia gravis in a young Nigerian girl.

Authors:  Salisu Abdullahi Balarabe; Mohammad Dantani Adamu; Musa Mamman Watila; Nma Jiya
Journal:  BMJ Case Rep       Date:  2015-09-03

Review 8.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

9.  Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.

Authors:  Sven Jarius; Klemens Ruprecht; Brigitte Wildemann; Tania Kuempfel; Marius Ringelstein; Christian Geis; Ingo Kleiter; Christoph Kleinschnitz; Achim Berthele; Johannes Brettschneider; Kerstin Hellwig; Bernhard Hemmer; Ralf A Linker; Florian Lauda; Christoph A Mayer; Hayrettin Tumani; Arthur Melms; Corinna Trebst; Martin Stangel; Martin Marziniak; Frank Hoffmann; Sven Schippling; Jürgen H Faiss; Oliver Neuhaus; Barbara Ettrich; Christian Zentner; Kersten Guthke; Ulrich Hofstadt-van Oy; Reinhard Reuss; Hannah Pellkofer; Ulf Ziemann; Peter Kern; Klaus P Wandinger; Florian Then Bergh; Tobias Boettcher; Stefan Langel; Martin Liebetrau; Paulus S Rommer; Sabine Niehaus; Christoph Münch; Alexander Winkelmann; Uwe K Zettl U; Imke Metz; Christian Veauthier; Jörn P Sieb; Christian Wilke; Hans P Hartung; Orhan Aktas; Friedemann Paul
Journal:  J Neuroinflammation       Date:  2012-01-19       Impact factor: 8.322

10.  Are nonintestinal inflammatory diseases and celiac disease linked?: Nonintestinal inflammatory and celiac disease.

Authors:  Roberto Bergamaschi
Journal:  Hepat Mon       Date:  2011-01       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.